Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus

Nucleosides, Nucleotides and Nucleic Acids

Volumn 25, Issue 4-6, 2006, Pages 635-645

  Fujimuro, Masahiro ^a   Inoue, Hisanori ^a   Teishikata, Yasuhiro ^a   Ishida, Yuriko ^a   Yokosawa, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Acyclovir (ACV); Epstein barr virus (EBV); Ganciclovir (GCV); Human herpesvirus 8 (HHV 8); Kaposi's sarcoma associated herpesvirus (KSHV)

Indexed keywords

ACICLOVIR; CASPASE 7; CASPASE 8; GANCICLOVIR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ASSAY; EPSTEIN BARR VIRUS; EVALUATION; FLOW CYTOMETRY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOBLOTTING; LYMPHOMA CELL LINE; PRIMARY EFFUSION LYMPHOMA; RAJI CELL;

ACYCLOVIR; APOPTOSIS; CASPASE 3; CASPASE 7; GANCICLOVIR; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 8;

EID: 33747612593     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770600686311     Document Type: Article

References (20)

1. Jenner, R.G.; Boshoff, C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochimica et Biophysica Acta 2002, 1602, 1-22.
2. Gao, S.J.; Kingsley, L.; Li, M.; Zheng, W.; Parravicini, C.; Ziegler, J.; Newton, R.; Rinaldo, C.R.; Saah, A.; Phair, J.; Detels, R.; Chang, Y.; Moore, P.S. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Medicine 1996, 2, 925-928.
3. Chatlynne, L.G.; Lapps,W.; Handy, M.; Huang, Y.Q.; Masood, R.; Hamilton, A.S.; Said, J.W.; Koeffler, H.P.; Kaplan, M.H.; Friedman-Kien, A.; Gill, P.S.; Whitman, J.E.; Ablashi, D.V. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998, 92, 53-58.
4. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in aids-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
5. Ablashi, D.V.; Chatlynne, L.G.; Whitman, J.E.; Cesarman, E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clinical Microbiology Reviews 2002, 15, 439-464.
6. Russo, J.J.; Bohenzky, R.A.; Chien, M.C.; Chen, J.; Yan, M.; Maddalena, D.; Parry, J.P.; Peruzzi, D.; Edelman, I.S.; Chang, Y.; Moore, P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences USA 1996, 93, 14862-14867.
7. Ballestas, M.E.; Chatis, P.A.; Kaye, K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999, 284, 641-644.
8. Radkov, S.A.; Kellam, P.; Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nature Medicine 2000, 6, 1121-1127.
9. Friborg, J.J.; Kong, W.; Hottiger, M.O.; Nabel, G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999, 402, 889-894.
10. Fujimuro, M.; Wu, F.Y.; apRhys, C.; Kajumbula, H.; Young, D.B.; Hayward, G.S.; Hayward, S.D. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nature Medicine 2003, 9, 300-306.
11. Fujimuro, M.; Hayward, S.D. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3β. Journal of Virology 2003, 77, 8019-8030.
12. Hsu, J.L.; Glaser, S.L. Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implications. Critical Reviews in Oncology Hematology 2000, 34, 27-53.
13. Kedes, D.H.; Ganem, D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Journal of Clinical Investigation 1997, 99, 2082-2086.
14. Medveczky, M.M.; Horvath, E.; Lund, T.; Medveczky, P.G. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997, 11, 1327-1332.
15. Neyts, J.; De Clercq, E. Antiviral drug susceptibility of human herpesvirus 8. Antimicrobial Agents and Chemotherapy 1997, 41, 2754-2756.
16. Cannon, J.S.; Hamzeh, F.; Moore, S.; Nicholas, J.; Ambinder, R.F. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology 1999, 73, 4786-4793.
17. Gustafson, E.A.; Schinazi, R.F.; Fingeroth, J.D. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. Journal of Virology 2000, 74, 684-692.
18. Lock, M.J.; Thorley, N.; Teo, J.; Emery, V.C. Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. Journal of Antimicrobial Chemotherapy 2002, 49, 359-366.
19. Zhu, W.; Burnette, A.; Dorjsuren, D.; Roberts, P.E.; Huleihel, M.; Shoemaker, R.H.; Marquez, V.E.; Agbaria, R.; Sei, S. Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus. Antimicrobial Agents and Chemotherapy 2005, 49, 4965-4973.
20. Muller, M.; Wilder, S.; Bannasch, D.; Israeli, D.; Lehlbach, K.; Li-Weber, M.; Friedman, S.L.; Galle, P.R.; Stremmel, W.; Oren, M.; Krammer, P.H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. Journal of Experimental Medicine 1998, 188, 2033-2045.